Solifenazin\'e bağlı diskinezi
Aşırı aktif mesane inkontinans olsun ya da olmasın urgency ile ilişkili kronik bir durumdur. Solifenazin günde tek doz kullanılan selektif antimuskarinik bir ajandır. Günde 5 mg olarak başlanır, tolere edilebilirse 10 mg\'a artırılabilir. Biz burada solifenazin kullanımı sonrası ortaya çıkan ve ilacın kesilmesini takiben birkaç gün içinde ortadan kaybolan diskinezili bir olguyu sunduk.
Anahtar Kelimeler:
Aşırı aktif mesane, solifenazin, diskinezi.
Solifenacin induced dyskinesia
Overactive bladder syndrome is a chronic condition characterised by urgency, with or without associated urge incontinence. Solifenacin succinate is a once daily, bladder selective antimuscarinic available. The recommended dose is 5 mg once daily and can be increased to 10 mg once daily if 5 mg is well tolerated. We report here a case with dyskinesia emerged following the use of solifenacin, and disappeared in a few days with stopping the agent.
Keywords:
Overactive bladder syndrome, solifenacin, dyskinesia,
___
- Wagg A, Wyndaele JJ, Sieber P. Efficacy and toler- ability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother 2006;4(1):14-24.
- Chancellor MB, Zinner N, Whitmore K, et al. Efficacy of solifenacin in patients previously treated with tolt- erodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study. Clin Ther 2008;30(10):1766-81.
- Basra R, Kelleher C. A review of solifenacin in the treat- ment of urinary incontinence. Ther Clin Risk Manag. 2008;4(1):117-28.
- Cardozo L, Lisec M, Millard R, et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004;172(5):1919-24.
- Suzuki M, Noguchi Y, Okutsu H, Ohtake A, Sasamata M. Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance re- sponse test. Eur J Pharmacol 2007;557(2-3):154-8.
- Piecoro LT, Wermeling DP, Schmitt FA, Ashford JW. Seizures in patients receiving concomitant antimus- carinics and acetylcholinesterase inhibitor. Pharma- cotherapy 1998;18(5):1129-32.
- Başlangıç: 2010
- Yayıncı: Sağlık Araştırmaları Derneği
Sayıdaki Diğer Makaleler
Nilesh Kumar MİTRA, Kanakeswary KRİSHNAN, Chong Chung HİONG, Yen Nee DİNG, Hsiao Lung EDDİE, Archana SİKARWAR
Solifenazin\'e bağlı diskinezi
Ersel Dağ, Burcu Azapoğlu, Turgut Deniz
Multipl sklerozlu hastalarda serum prolidaz ve iskemi modifiye albümin düzeyleri
Mehmet Uğur Çevik, Yavuz Yücel, Adalet Arıkanoğlu, Sefer Varol, Eşref Akıl, Hatice Yüksel, Mehmet Ufuk Aluçlu
Kahramanmaraş'ta gerçekleşen toplu kardeş intiharlarının incelenmesi
Ramazan Karanfil, Alper KETEN, Cem Zeren, Mustafa Haki Sucaklı